Caroline Lemarchand

836 total citations
8 papers, 658 citations indexed

About

Caroline Lemarchand is a scholar working on Biomaterials, Pulmonary and Respiratory Medicine and Pharmaceutical Science. According to data from OpenAlex, Caroline Lemarchand has authored 8 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biomaterials, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Pharmaceutical Science. Recurrent topics in Caroline Lemarchand's work include Nanoparticle-Based Drug Delivery (5 papers), Oral health in cancer treatment (2 papers) and Advanced Drug Delivery Systems (2 papers). Caroline Lemarchand is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Oral health in cancer treatment (2 papers) and Advanced Drug Delivery Systems (2 papers). Caroline Lemarchand collaborates with scholars based in France and Germany. Caroline Lemarchand's co-authors include Patrick Couvreur, Ruxandra Gref, Rainer Müller, Emmanuel Garcion, Catherine Passirani, Madeleine Besnard, Sylviane Lesieur, H. Hommel, Ahmed Besheer and Béatrice Vacher and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Cancer Research.

In The Last Decade

Caroline Lemarchand

8 papers receiving 635 citations

Peers

Caroline Lemarchand

BIOMA

PS

MB

BE

MC

Sara Bersani Italy

Yong‐Ho Shim South Korea

Tsz Chung Lai United States

Julio C. Cuggino Argentina

Larisa Sheihet United States

Jacob D. Ramsey United States

Jayaganesh V. Natarajan Singapore

Mazdak Asadian‐Birjand Germany

Benoı̂t Vroman Belgium

Jubo Liu Canada

Sara Bersani Italy

Caroline Lemarchand

307 ×0.8

BIOMA

149 ×0.8

PS

270 ×1.5

MB

163 ×1.0

BE

50 ×0.5

MC

Citations per year, relative to Caroline Lemarchand Caroline Lemarchand (= 1×) peers Sara Bersani

Countries citing papers authored by Caroline Lemarchand

Since Specialization

Citations

This map shows the geographic impact of Caroline Lemarchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Lemarchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Lemarchand more than expected).

Fields of papers citing papers by Caroline Lemarchand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Lemarchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Lemarchand. The network helps show where Caroline Lemarchand may publish in the future.

Co-authorship network of co-authors of Caroline Lemarchand

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Lemarchand. A scholar is included among the top collaborators of Caroline Lemarchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Lemarchand. Caroline Lemarchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Llópiz, Diana, Marta Ruiz, B. Vasseur, et al.. (2017). Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model. Cancer Research. 77(13_Supplement). 1059–1059. 1 indexed citations

2.

Lemarchand, Caroline, et al.. (2016). Abstract 2143: Mechanistic study of the relative cytotoxicity of doxorubicin loaded nanoparticle formulation compared to free doxorubicin in hepatocellular carcinoma (HCC) cell lines. Cancer Research. 76(14_Supplement). 2143–2143. 4 indexed citations

3.

Attali, P, et al.. (2014). Effect of clonidine on proinflammatory cytokine levels in ex vivo human oral mucosa.. Journal of Clinical Oncology. 32(15_suppl). e20689–e20689. 2 indexed citations

4.

Attali, P, et al.. (2014). Effect of topical clonidine on the duration and severity of radiation-induced oral mucositis (OM) in a translational hamster model.. Journal of Clinical Oncology. 32(15_suppl). 10091–10091. 4 indexed citations

5.

Lemarchand, Caroline, Ruxandra Gref, Sylviane Lesieur, et al.. (2005). Physico-chemical characterization of polysaccharide-coated nanoparticles. Journal of Controlled Release. 108(1). 97–111. 46 indexed citations

6.

Lemarchand, Caroline, Ruxandra Gref, Catherine Passirani, et al.. (2005). Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials. 27(1). 108–118. 153 indexed citations

7.

Lemarchand, Caroline, Ruxandra Gref, & Patrick Couvreur. (2004). Polysaccharide-decorated nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 58(2). 327–341. 386 indexed citations

8.

Lemarchand, Caroline, et al.. (2003). Novel Polyester-Polysaccharide Nanoparticles. Pharmaceutical Research. 20(8). 1284–1292. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact